JNJ
Johnson & Johnson
Stock
$271.95+0.73 (+0.27%)Close Sep 28, 2026
| Shareholders' equity (Q2 FY2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $85.0B | +8.3% | 5.2% | 1.4% |
| Shareholders' equity (Q2 FY2026) | $85.0B |
|---|---|
| YoY | +8.3% |
| 5-year CAGR | 5.2% |
| 10-year CAGR | 1.4% |
Shareholders' equity
| Period | Equity | YoY |
|---|---|---|
| FY2025 | $81.5B | +14.1% |
| FY2024 | $71.5B | +3.9% |
| FY2023 | $68.8B | −10.5% |
| FY2022 | $76.8B | +3.8% |
| FY2021 | $74.0B | +17.0% |
| FY2020 | $63.3B | +6.4% |
| FY2019 | $59.5B | −0.5% |
| FY2018 | $59.8B | −0.7% |
| FY2017 | $60.2B | −14.6% |
| FY2016 | $70.4B | −1.0% |
| FY2015 | $71.2B | +2.0% |
| FY2014 | $69.8B | −5.8% |
| FY2013 | $74.1B | +14.2% |
| FY2012 | $64.8B | +13.6% |
| FY2011 | $57.1B | +0.9% |
| FY2010 | $56.6B | +13.2% |
| FY2009 | $50.0B | +17.6% |
| FY2008 | $42.5B | −1.9% |
| FY2007 | $43.3B | — |